Cancer Killing Breakthrough with Leukemia May Lead to Gene Attacks on Other Cancers
‘Within three weeks, the tumors had been blown away’ - Watch Video
Aug. 10, 2011 - In a cancer treatment breakthrough 20 years in the making, researchers have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells, according to the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine. The medical team reports the cancer-killing cells are still active.
The protocol, which involves removing patients' cells and modifying them in Penn's vaccine production facility, then infusing the new cells back into the patient's body following chemotherapy, provides a tumor-attack roadmap for the treatment of other cancers, including those of the lung and ovaries and myeloma and melanoma.
I am of a mixed reaction, albeit netting an overall joyous one. I'm glad we have made a success here and that it may potentially lead to breakthroughs in other areas.
At the same time this seems so deceptively simple...there has GOT to be more to it. You're telling me that it's as simple as modifying a patient's white blood cells, reprogramming them and injecting them back into the patient? I'm sure there had to be some significant work done to this end to even get this far but it just seems so...un-complicated. Perhaps I'm just used to so many real solutions and answers not being straightforward.
In any case I am glad that this breakthrough has come to fruition. Hopefully more good news will result--like another step or two in finding those elusive cures for cancer!